Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV type 1 transmission and AIDS disease progression

American Journal of Human Genetics

Volumn 79, Issue 1, 2006, Pages 120-128

  Modi, William S ^a,h   Lautenberger, James ^b   An, Ping ^a   Scott, Kevin ^a   Goedert, James J ^c   Kirk, Gregory D ^d   Buchbinder, Susan ^e   Phair, John ^f   Donfield, Sharyne ^g   O'Brien, Stephen J ^b   Winkler, Cheryl ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g RHO INC   (United States)

^h ZOOLOGICAL SOCIETY OF SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN PARC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ALLELE; ARTICLE; CCL18 GENE; CCL3 GENE; CCL4 GENE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHROMOSOME 17Q; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE COURSE; DISEASE TRANSMISSION; FIBROBLAST; GENE; GENE CLUSTER; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIGAND BINDING; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MAST CELL; NATURAL KILLER T CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACE; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UNITED STATES; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745270102     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/505331     Document Type: Article

References (39)

1. DeVico AL, Gallo RC (2004) Control of HIV-1 infection by soluble factors of the immune response. Nat Rev Microbiol 2:401-413
2. Winkler C, An P, O'Brien SJ (2004) Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Genet Spec No 1 13:R9-R19
3. Walker CM, Moody DJ, Stites DP, Levy JA (1986) CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566
4. Mackewicz C, Levy JA (1992) CD8+ cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res Hum Retroviruses 8:1039-1050
5. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815
6. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179
7. Luster AD (1998) Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445
8. Modi WS (2004) CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17q12. Genomics 83:735-738
9. Xin X, Nakamura K, Liu H, Nakayama EE, Goto M, Nagai Y, Kitamura Y, Shioda T, Iwamoto A (2001) Novel polymorphisms in human macrophage inflammatory protein-1 alpha (MIP-1α) gene. Genes Immun 2:156-158
10. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, Anderson SA, Walter EA, Stephan KT, Hammer MF, Mangano A, Sen L, Clark RA, Ahuja SS, Dolan MJ, Ahuja SK (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1α: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 98:5199-5204
11. Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H (1998) Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 279:35-40
12. Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr, Evatt BL, Gomperts ED, Hoots WK, Jason J, Loveland KA, McKinlay SM, Stehbens JA (1993) Hemophilia Growth and Development Study: design, methods, and entry data. Am J Pediatr Hematol Oncol 15:208-218
13. Goedert JJ, Kessler CM, Aledort LM, Biggar RJ, Andes WA, White GC II, Drummond JE, Vaidya K, Mann DL, Eyster ME, Ragni MV, Lederman MM, Cohen AR, Bray GL, Rosenberg PS, Friedman RM, Hilgartner MW, Blattner WA, Kroner B, Gail MH (1989) A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 321:1141-1148
14. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126:310-318
15. Detels R, Liu Z, Hennessey K, Kan J, Visscher BR, Taylor JMG, Hoover DR, Rinaldo CR Jr, Phair JP, Saah AJ, Giorgi JV, for the Multicenter AIDS Cohort Study (1994) Resistance to HIV-1 infection. J Acquir Immune Defic Syndr 7:1263-1269
16. Rutherford GW, Lifson AR, Hessol NA, Darrow WW, O'Malley PM, Buchbinder SP, Barnhart JL, Bodecker TW, Cannon L, Doll LS, Holmberg SD, Harrison JS, Rogers MF, Werdegar D, Jaffe HW (1990) Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 301:1183-1188
17. Kroner BL, Rosenberg PS, Aledort LM, Alvord WG, Goedert JJ (1994) HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 7:279-286
18. Modi WS, Scott K, Goedert JJ, Vlahov D, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C (2005) Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun 6:691-698
19. Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, Schrager LK, Phair JP, for the Multicenter AIDS Cohort Study Investigators (1998) Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA 280:1497-1503
20. Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, Vlahov D, Gallant JE (2001) Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 15:1707-1715
21. Centers for Disease Control and Prevention (1992) 1993 Revised classification system for HIV infection and an expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41:1-19
22. Centers for Disease Control and Prevention (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkl Rep Suppl 1 36:1S-15S
23. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
24. Nakao M, Nomiyama H, Shimada K (1990) Structures of human genes coding for cytokine LD78 and their expression. Mol Cell Biol 10:3646-3658
25. Modi WS, Goedert JJ, Strathdee S, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C (2003) MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS 17:2357-2365
26. Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169
27. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
28. McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF, Detels R, Hajeer AH, Murphy PM (2000) Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 14:2671-2678
29. An P, Nelson GW, Wang L, Donfield S, Goedert JJ, Phair J, Vlahov D, Buchbinder S, Farrar WL, Modi W, O'Brien SJ, Winkler CA (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 99:10002-10007
30. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-1862
31. Ober C (2005) Perspectives on the past decade of asthma genetics. J Allergy Clin Immunol 116:274-278
32. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD (1998) Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 63:1839-1851
33. Gunther C, Bello-Fernandez C, Kopp T, Kund J, Carballido-Perrig N, Hinteregger S, Fassl S, Schwarzler C, Lametschwandtner G, Stingl G, Biedermann T, Carballido JM (2005) CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 174:1723-1728
34. Higgins DG, Thompson JD, Gibson TJ (1996) Using CLUSTAL for multiple sequence alignments. Methods Enzymol 266:383-402
35. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F (1997) HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186:139-146
36. Signoret N, Rosenkilde MM, Klasse PJ, Schwartz TW, Malim MH, Hoxie JA, Marsh M (1998) Differential regulation of CXCR4 and CCR5 endocytosis. J Cell Sci 111:2819-2830
37. Vila-Coro AJ, Mellado M, Martin de Ana A, Lucas P, del Real G, Martinez AC, Rodriguez-Frade JM (2000) HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc Natl Acad Sci USA 97:3388-3393
38. Gross E, Amella CA, Pompucci L, Franchin G, Sherry B, Schmidtmayerova H (2003) Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection. J Leukoc Biol 74:781-790
39. Weiss RA, McMichael AJ (2004) Social and environmental risk factors in the emergence of infectious diseases. Nat Med 10:S70-S76